Parra MA, Gazes Y, Habeck C, Stern Y. Exploring the Association between Amyloid-β and Memory Markers for Alzheimer's Disease in Cognitively Unimpaired Older Adults.
J Prev Alzheimers Dis 2024;
11:339-347. [PMID:
38374740 PMCID:
PMC11007669 DOI:
10.14283/jpad.2024.11]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/21/2024]
Abstract
BACKGROUND
Memory tests vary in their sensitivity for detection of pre-symptomatic Alzheimer's disease (AD). The Visual Short-Term Memory Binding Test (VSTMBT) identifies AD-related performance deficits in older adults who are otherwise cognitively unimpaired.
OBJECTIVE
We investigated the association of this psychometric measure with brain amyloidosis and atrophy.
DESIGN
Cross-sectional mixed and correlational.
SETTING
Cognitive Reserve Study from Columbia University.
PARTICIPANTS
a sample of 39 cognitively unimpaired older adults (Age: M=65.3, SD=3.07) was obtained from the above study.
MEASUREMENTS
Extensive neuropsychological and neuroimaging (MRI and amyloid-β PET) assessments were carried out.
RESULTS
Performance on the VSTMBT allowed us to split the sample into Low Binding Cost (LBC, N=21) and High Binding Cost (HBC, N=18). Groups were matched according to age [p=0.702], years of education [0.071], and sex [p=0.291]. HBC's performance was comparable to that seen in symptomatic AD. Groups only differed in their amyloid-β deposition on PET in regions of the right ventral stream linked to visual cognition and affected early in AD pathogenesis (lateral-occipital cortex, p = 0.008; fusiform gyrus, p = 0.017; and entorhinal cortex, p = 0.046). Other regions known to be linked to low-level visual integration function also revealed increased amyloid-β deposition in HBC.
CONCLUSIONS
VSTMB deficits are associated with neuropathogenesis (i.e., amyloid-β deposition) in the earliest affected regions in pre-symptomatic AD. The VSTMB test holds potential for the identification of cognitively unimpaired older adults with very early AD pathogenesis and may thus be a useful tool for early intervention trials or other forms of clinical research.
Collapse